Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging PI-2301 vs placebo in relapsing-remitting multiple sclerosis
2009-012716-40Phase 2Terminated
- Sponsor
- Peptimmune
- Start
- Dec 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of plovamer acetate in multiple sclerosis (MS) (3 arms), sponsored by Peptimmune. Started Dec 2009; status: terminated.
02
Drugs
plovamer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-012716-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012716-40.